NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses

BACKGROUND: Therapeutic tumor vaccine (TTV) that induces tumor-specific immunity has enormous potentials in tumor treatment, but high heterogeneity and poor immunogenicity of tumor seriously impair its clinical efficacy. Herein, a novel NIR responsive tumor vaccine in situ (HA-PDA@IQ/DOX HG) was pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lirong, Zhang, Jingjing, Xu, Lixia, Zhuang, Zijian, Liu, Jingjin, Liu, Suwan, Wu, Yunchao, Gong, Aihua, Zhang, Miaomiao, Du, Fengyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130144/
https://www.ncbi.nlm.nih.gov/pubmed/34001148
http://dx.doi.org/10.1186/s12951-021-00880-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130144/
https://www.ncbi.nlm.nih.gov/pubmed/34001148
http://dx.doi.org/10.1186/s12951-021-00880-x

Ejemplares similares